NUDT16L2P: A Potential Drug Target and Biomarker (G152195)

Target Name: NUDT16L2P

NCBI ID: G152195

NUDT16L2P

Other Name(s): Nudix hydrolase 16 like 2, pseudogene, transcript variant 1 | NUDT16P1 | nudix hydrolase 16 like 2, pseudogene | NUDT16P

NUDT16L2P: A Potential Drug Target and Biomarker

Nudix hydrolase 16 like 2 (NUDT16L2P), also known as pseudogene 16, is a gene that encodes a protein involved in the immune response and inflammation. The protein produced by this gene has been shown to play a crucial role in the regulation of inflammation and infection, making it an attractive candidate for drug development.

The immune response is a critical function of the body that helps protect it from infection and disease. NUDT16L2P is a key enzyme in this process, as it helps to remove pathogens and damaged cells from the body. It is part of the NOD2 family of enzymes, which are involved in the production of inflammatory cytokines.

NUDT16L2P is a pseudogene, which means that it is a genetic variation in a gene that has not been expressed in the cell. However, it is thought to have a functional role in the cell, as it is expressed in the cell and can be detected using techniques such as qRT-PCR and western blotting.

One of the key functions of NUDT16L2P is its role in the regulation of inflammation. This is important because chronic inflammation can lead to a host of diseases, including heart disease, diabetes, and cancer. NUDT16L2P has been shown to play a role in the regulation of inflammation by promoting the production of anti-inflammatory cytokines.

In addition to its role in inflammation, NUDT16L2P has also been shown to be involved in the regulation of cell death. This is important because chronic cell death can contribute to the development of cancer and other diseases. NUDT16L2P has been shown to play a role in the regulation of cell death by promoting the production of programmed cell death (apoptosis) in response to environmental stressors, such as UV radiation and toxic chemicals.

The potential drug target for NUDT16L2P is its role in the regulation of inflammation and cell death. Drugs that can inhibit NUDT16L2P activity and enhance its expression have the potential to treat a wide range of diseases, including cancer, autoimmune disorders, and inflammatory diseases.

In addition to its potential therapeutic applications, NUDT16L2P is also a potential biomarker for a variety of diseases. For example, high levels of NUDT16L2P expression have been shown to be associated with the development of certain types of cancer, including breast and ovarian cancer. Additionally, NUDT16L2P has been shown to be involved in the regulation of cell death, which is a potential biomarker for certain types of cancer, such as melanoma.

Overall, NUDT16L2P is a promising candidate for drug development due to its role in the regulation of inflammation and cell death. Further research is needed to fully understand its functions and potential therapeutic applications.

Protein Name: Nudix Hydrolase 16 Like 2, Pseudogene

The "NUDT16L2P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NUDT16L2P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets